crosses is the restriction of P. falciparum pre-erythrocytic stage development to humans and a small number of nonhuman primates including chimpanzees 4 . Moreover, the US National Institutes of Health (NIH) has recently halted the use of chimpanzees for biomedical research. Thus, a new model for genetic crossing studies would be immensely valuable for malaria genetics research. Recently, we demonstrated that a human hepatocyte-liver chimeric mouse model (the FRG huHep mouse) supports complete P. falciparum liver stage development, formation of exoerythrocytic merozoites and transition to asexual blood stage replication when these mice are injected with human red blood cells (huRBCs) 5 . Consequently, we predicted that the FRG huHep mouse harboring huRBCs could be used as a novel and versatile vehicle for experimental P. falciparum crosses.
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As a proof of concept, we initially staged a cross between the documented chloroquine (CQ)-resistant strain GB4 (refs. 6,7) and a CQ-sensitive transgenic strain NF54HT-GFP-luc, which expresses a GFP-luciferase fusion 8 and is resistant to the human dihydrofolate reductase (DHFR) inhibitor WR99210 owing to transgene integration in the pf47 locus on chromosome 13 . Mature in vitro gametocyte cultures for both strains 9 were mixed for cross-fertilization and fed to Anopheles stephensi mosquitoes 10 . Sporozoites were isolated from mosquito salivary glands, and approximately 4 million sporozoites were injected intravenously into each of two FRG huHep mice. In vivo imaging demonstrated luciferase activity in the mouse liver indicative of parasite liver stage development 8 (Fig. 1b) . To allow for liver stage-to-blood stage transition, we intravenously injected huRBCs into the mice twice, at 6 and 7 d after sporozoite injection-a regimen that maintains huRBC numbers in the mouse and enables initiation of in vivo blood stage development of transitioned parasites. Four hours after the second huRBC injection, we euthanized and exsanguinated the mice to isolate the circulating Genetic crosses of phenotypically distinct strains of the human malaria parasite Plasmodium falciparum are a powerful tool for identifying genes controlling drug resistance and other key phenotypes. Previous studies relied on the isolation of recombinant parasites from splenectomized chimpanzees, a research avenue that is no longer available. here we demonstrate that human-liver chimeric mice support recovery of recombinant progeny for the identification of genetic determinants of parasite traits and adaptations.
Genetic crosses in the human malaria parasite P. falciparum have been used with outstanding success to locate the genetic determinants of important biomedical traits such as drug resistance and host specificity [1] [2] [3] . However, conducting genetic crosses with P. falciparum is technically difficult and expensive (Fig. 1a) , and only three P. falciparum genetic crosses have been performed over a 28-year period. The biggest obstacle to routine generation of genetic 1 (a) Schematic of experimental P. falciparum experimental crosses between two parasite strains (green and white) and isolation of recombinant progeny (striped). (b) Sporozoites (Spz) from crosses between NF54HT-GFP-luc (NF54-GFP-luc) with strains GB4, 7G8 and NHP* were injected into FRG huHep mice, and liver stage development was visualized on day 6 after inoculation by assaying luciferase activity in vivo (left). Liver sections from the NF54HT-GFP-luc × NHP* cross mouse were subjected to an indirect immunofluorescence assay (center), and the representative image (from analysis of ten nonserially isolated liver slices) shows the location of four liver stage parasites (yellow arrows; merozoite surface protein 1 expression shown in turquoise) in the highly humanized liver (human fumaryl acetoacetate hydrolase expression shown in magenta). DNA (blue) was stained with 4′,6-diamidino-2-phenylindole (DAPI). Scale bar, 100 µm. After liver stageto-blood stage transition in the same cross, a representative (from 40 fields of view at 1,000×) Giemsa-stained smear (right) shows substantial blood stage parasitemia (yellow arrows point to infected red blood cells). Scale bar, 10 μm. npg a single allele at every locus genotyped, thereby confirming the clonality of all progeny lines. The 44 unselected progeny comprised 15 independent recombinants that were represented between 1 and 11 times (Fig. 2a) , and each unique independent recombinant varied from all other clones at a minimum of one marker. We found that six recombinant genotypes were repeated in multiple progeny (Fig. 2a) . Of interest, we did not isolate any progeny with parental genotypes, a result indicating rare or non-existent selfing (malefemale gamete pairing from the same parent). We next used rarefaction, a resampling approach widely used in ecology for estimating the numbers of species present in a community from a subsample, to estimate the total numbers of independent progeny present 12 ( Fig. 2a) . These methods estimate 33 (95% confidence interval (CI): 19-96) independent recombinants for this cross, and that just over 150 clones would need to be sampled to attain this number.
Previous crosses in chimpanzees used parasites adapted for longterm laboratory rearing, but the utility of experimental genetic crosses will be most powerfully realized using fresh parasite isolates from clinical settings to study, for instance, emerging drug resistance 13 . To explore feasibility, we produced gametocyte cultures of a recent cloned field isolate (NHP*) 14 and crossed NHP* with NF54HT-GFP-luc. After injection of approximately 6.2 million P. falciparum-infected huRBCs. Giemsa-stained thin blood smears confirmed the liver stage-to-blood stage transition (parasitemia, i.e., the fraction of infected huRBCs, was <0.1% at this time point). We subsequently enriched infected blood with huRBCs and maintained in in vitro culture until parasitemia reached 1% at day 5. As an initial screen for recombinant progeny, we treated blood stage cultures with the antimalarial drugs WR99210 and CQ, reasoning that haploid parasites surviving this dual drug treatment would be recombinant, having inherited independent drug-resistant genes from each parent (mutant human DHFR from NF54HT-GFP-luc and the mutant P. falciparum CQ-resistant transporter (pfcrt) on chromosome 7 from GB4). Individual progeny were cloned by limiting dilution, and ten progeny (lines derived from a single infected cell) were confirmed to each carry the integration in pf47 and the CQ-resistant mutant pfcrt ( Supplementary Fig. 1 and Supplementary Table 1 ). This result unambiguously demonstrates that the progeny were products of meiotic recombination.
We next performed a cross between NF54HT-GFP-luc and 7G8, a parasite line previously used in a cross to demonstrate the importance of the pfrh5 gene in erythrocyte invasion 1 . Mature gametocyte cultures of each strain were mixed and fed to mosquitoes, and approximately 5.1 million sporozoites were injected into an FRG huHep mouse. We observed liver stage infection (Fig. 1b) , and after liver stage-to-blood stage transition, in vitro blood stage parasites were cloned by limiting dilution 3 d after culture initiation. We genotyped 44 unselected progeny from this cross to evaluate Mendelian chromosomal assortment and recombination using an optimized set of 22 polymorphic microsatellites 11 spanning all 14 parasite chromosomes ( Fig. 2a and Supplementary Table 2) . We saw figure 2 | Analysis of recombinant progeny from P. falciparum crosses. (a) Genotyping results for clonal progeny obtained from three experimental P. falciparum genetic crosses between NF54HT-GFP-luc (blue) × GB4 (orange), NF54HT-GFP-luc × 7G8 (green) and NF54HT-GFP-luc × NHP* (yellow) (crosses correspond to top, center and bottom subpanels, respectively). 22 microsatellite markers were genotyped across the 14 chromosomes (Chr). Markers in gray indicate microsatellites that were indistinguishable between the two parents. The number of cloned progeny carrying identical haplotypes is listed to the right of each haplotype; when a single haplotype was recovered, no number is listed. The rarefaction plots (right) estimate the total number of progeny present for each cross, with 95% confidence intervals npg sporozoites into a mouse, the infected liver showed a high luciferase signal (Fig. 1b) . On liver sections taken after mouse exsanguination, indirect immunofluorescence assay using an antibody to P. falciparum merozoite surface protein 1 confirmed a high infection rate in the mouse (Fig. 1b) . After the liver stage-to-blood stage transition, a Giemsa-stained smear of blood from the mouse showed a high level of huRBCs infected with P. falciparum ring stage parasites (Fig. 1b) , and after only 2 d of in vitro blood stage culture, blood stage parasitemia reached 1%. Microsatellite analysis of the cloned progeny demonstrated the diversity of this cross: of 25 cloned progeny, we isolated 20 independent recombinants each carrying a unique allele combination (three clones carried alleles from only the NF54HT-GFP-luc parent, and only two genotypes were represented twice among the cloned progeny) (Fig. 2a) . Rarefaction curves estimated that 72 (95% CI: 36-198) independent progeny were generated (Fig. 2a) , and that this number of independent clones could be isolated from just over 100 cloned progeny lines.
To extend our genetic analysis further for the NF54HT-GFP-luc × NHP* cross, we sequenced the genomes of 14 independent recombinants and both parents. The parental sequences differed at 7,536 high-confidence single-nucleotide polymorphisms (SNPs), revealing 726 crossovers (Fig. 2b, Supplementary Fig. 2 and Supplementary Table 3) in the progeny and a map length of 2,210 cM (10.4 kb/cM) ( Fig. 2c and Supplementary Table 3) . The proportions of SNPs inherited from each parent centered on 50% in the progeny (Supplementary Fig. 3) , which is consistent with Mendelian expectations, and the recombination parameters are comparable to those observed in the three previous crosses using chimpanzees 11, 15 .
A large number of progeny carrying randomly assorting and segregating chromosomes, as well as ample recombination, are essential for high-resolution mapping of genes that confer phenotypes. From the three crosses we performed, 4, 15 and 20 independent progeny have been isolated (Fig. 2a and Supplementary Table 4) . Rarefaction estimates based on the rate of discovery of new genotypes suggest that many more independent progeny can be recovered from the NF54HT-GFP-luc × NHP* cross. However, we isolated just four independent progeny from the initial NF54HT-GFP-luc × GB4 cross (Fig. 2a) . This is likely in part due to the double-drug-selection regimen, which removes recombinants that do not carry both resistance genes. In the other two crosses, where we did not employ drug selection, the estimated numbers of progeny that could be isolated are comparable (NF54HT-GFP-luc × 7G8) (Fig. 2a) or exceed (NF54HT-GFP-luc × NHP*) (Fig. 2a) those isolated from previous chimpanzee crosses 11, 15 . We speculate that the success in deriving large number of recombinants from the NF54HT-GFP-luc × NHP* cross (Fig. 2a and Supplementary  Table 4 ) in part resulted from the use of a highly transmissible parasite that we recently isolated from a patient. Whole-genome sequencing of 14 progeny from the NF54HT-GFP-luc × NHP* cross revealed recombination patterns characteristic of previous crosses conducted using chimpanzees, thus demonstrating the power of the FRG huHep mouse model to yield P. falciparum progeny for linkage mapping (Fig. 2b and Supplementary Fig. 2 ). Further optimization of the procedures described will improve the efficiency with which recombinant progeny are recovered.
The spread of artemisinin (ART) resistance in southeast Asia 13 is an emergent crisis in malaria control. Population genetics and a 5-year laboratory selection of ART-resistant parasites led to the discovery of a marker for ART resistance, the Kelch locus 14, 16, 17 .
The methodology presented here could have significantly accelerated the identification of this marker. Well-defined genetic crosses between ART-resistant and susceptible strains now promise to improve our understanding of the genetic and functional underpinnings of ART resistance. Furthermore, staging P. falciparum genetic crosses using the FRG huHep mouse model provides a powerful framework for integrated analysis of multiple layers of genomic-scale data ('systems genetics') to better understand biomedically important parasite traits. methods Methods and any associated references are available in the online version of the paper. FRG NOD huHep mice. Male and female FRG NOD huHep mice 18 with human chimeric livers were purchased from Yecuris Corporation. The mice are immunocompromised and should ideally be maintained in a barrier facility. In our hands, the mice were healthy throughout the course of experimentation. For each of the experimental genetic crosses performed, one or two FRG huHep mice were used for liver stage development and subsequent liver stage-to-blood stage transition. The mice were not formally randomized, nor were researchers blinded, before injection. No sample-size estimation was performed as there are no statistics presented where we try and detect an effect size between groups. The mice injected intravenously with P. falciparum sporozoites from the NF54HT-GFP-luc × GB4 cross and the NF54HT-GFP-luc × 7G8 cross were male and 6 months of age, and the mouse that received sporozoites from the NF54HT-GFP-luc × NHP* cross was female and 7 months of age. The mice had human albumin levels between 4.3 and 7.3 mg/mL. Mice used in the study were supplemented with NTBC at 8 mg/L in their drinking water on arrival and maintained on this dose until euthanasia.
P. falciparum sporozoite production and liver stage infection.
The A. stephensi mosquitoes used in this study were maintained at 27 °C and 75% humidity on a 12-h light/dark cycle. We followed MR4 protocols for larval stage and adult stage rearing; to this end, larvae were fed with finely ground Tetramin fish food, and adults were fed with cotton balls soaked in a solution of 8% dextrose and 0.05% para-aminobenzoic acid in water.
P. falciparum blood stage cultures were maintained in vitro in standard cell culture RPMI-1640 with 25 mM HEPES and 2 mM l-glutamine supplemented with 50 µM hypoxanthine and 10% A + human serum. An atmosphere of 5% CO 2 , 5% O 2 and 90% N 2 was used for growth, and infected P. falciparum red blood cells were subcultured into O + erythrocytes.
To initiate sexual stage development, we set up early passages (no more than ten passages) of asexual cultures at a parasitemia between 0.8% and 1% (mixed stages) and 5% hematocrit and maintained them with daily medium changes for up to 17 d. Mature gametocytes were fed to adult female mosquitoes 3-to 7-d post-emergence. To do this, gametocyte cultures were pelleted for 3 min at 800g and diluted to a 40% hematocrit using fresh A + human serum and O + erythrocytes at 37 °C. Mosquitoes were allowed to feed for 20 min, and the blood was maintained at 37 °C throughout.
Mosquitoes were maintained for up to 19 d, and the prevalence of infection was analyzed between days 7 and 10 by examining dissected midguts under light microscopy for the presence of oocysts. Salivary gland dissections were performed at days 14-19, and sporozoite numbers were enumerated using a hemocytometer. In order to minimize the deleterious effects of salivary gland extract injection into the mice, we used average sporozoite numbers per mosquito >30,000. Additionally, salivary gland dissection was performed to minimize the isolation of extraneous mosquito material.
Mice were injected intravenously into the tail vein with between approximately 4.0 million and 6.2 million P. falciparum salivary gland sporozoites in 200 µL of RPMI medium without supplements. Six days after sporozoite injection, liver stage luciferase activity was visualized (Fig. 1b) through imaging of whole bodies using the IVIS Lumina II animal imager (Caliper Life Sciences). Mice were injected with 100 µL of RediJect d-luciferin (PerkinElmer) intraperitoneally before being anesthetized using an isoflurane anesthesia system (XGI-8, Caliper Life Sciences). Animals were kept anesthetized during the measurements, which were performed within 5-10 min after the injection of d-luciferin. Bioluminescence imaging was acquired with a 10-cm FOV, medium binning factor and an exposure time of 5 min. Quantitative analysis of bioluminescence was performed by measuring the luminescence signal intensity using the ROI settings of the Living Image 3.0 software.
Liver stage-to-blood stage transition and in vitro culture of blood stages derived from FRG NOD huHep mouse infections. We have determined that the majority of liver stage parasites fully mature and release exoerythrocytic merozoites between 6 and 6.5 d after sporozoite infection. To maximize the number of transitioned ring stage parasites for downstream analysis, we injected mice with huRBCs twice before exsanguination: once at 6 d after sporozoite injection and a second time at 7 d after sporozoite injection. A second injection of huRBCs is performed to catch late-transitioning liver stage parasites. Some huRBCs injected into the mice are cleared by the spleen, but the majority survive in vivo, and thus liver stage parasites that mature and release exoerythrocytic merozoites after huRBC injection have the potential to invade huRBCs and begin to develop in vivo in the mouse. To this end, 6 d after sporozoite injection, we injected mice intravenously with 400 µL of packed O + huRBCs. The intravenous injection was repeated on day 7. Four hours after the second huRBC injection, mice were sacrificed and blood was removed by cardiac puncture in order to recover P. falciparum-infected huRBCs. The blood was added to 10 mL complete medium (RPMI-1640 with 25 mM HEPES, 2 mM l-glutamine, 50 µM hypoxanthine and 10% A + human serum) and pelleted by centrifugation at 200g. The supernatant along with the buffy coat (containing white blood cells) were then removed, and the red blood cells were washed three times with 10 mL complete medium, with pelleting and centrifugation as detailed above. After the third wash, an equal volume of packed O + huRBCs (approximately 400 µL) was added, and the total RBC pellet was resuspended in complete medium to 2% hematocrit. Cultures were split equally into six wells of a standard six-well plate and maintained in an atmosphere of 5% CO 2 , 5% O 2 and 90% N 2 . Cultures were fed daily, and 50 µL of freshly packed huRBCs were added every 5 d to each well. Once parasitemia reached 1%, serial dilutions of parasites were carried out to maintain healthy cultures. Additionally, cloning of parasites by limiting dilution was carried out in standard 96-well plates.
npg
A genetic map was constructed using the est.map function in R/qtl 26 in R v3.1.0 using the Haldane map function. As the parental lines were sequenced directly, each SNP in the progeny was designated by its parent of origin. We calculated pairwise allele sharing between progeny using the comparegeno function, and we assessed whether the observed data conformed to a normal distribution using the Shapiro-Wilk test for normality, implemented in the shapiro test function in R.
